34334-96-8

Basic information

• Product Name: 1H-Pyrazole,3-methyl-5-nitro-(9CI)
• Synonyms: 1H-Pyrazole,3-methyl-5-nitro-(9CI);5-Methyl-3-nitro-1H-pyrazole;3-methyl-5-nitro-1H-pyrazole(SALTDATA: FREE);3-nitro-5-Methylpyrazole;3(5)-Methyl-5(3)-nitropyrazol;3-Methyl-5-nitro-1(2)H-pyrazole;5-Methyl-3-nitropyrazol;5-Methyl-3-nitropyrazole
• CAS NO: 34334-96-8
• Molecular Formula: C₄H₅N₃O₂
• Molecular Weight: 127.103
• Product Categories: NITRO
• Mol File: 34334-96-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 335.712°C at 760 mmHg
• Flash Point: 156.833°C
• Appearance: /
• Density: 1.427g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.592
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 8.88±0.10(Predicted)
• CAS DataBase Reference: 1H-Pyrazole,3-methyl-5-nitro-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole,3-methyl-5-nitro-(9CI)(34334-96-8)
• EPA Substance Registry System: 1H-Pyrazole,3-methyl-5-nitro-(9CI)(34334-96-8)

Safety Data

• Hazardous Substances Data: 34334-96-8(Hazardous Substances Data)

Usage

InChI:InChI=1/C4H5N3O2/c1-3-2-4(6-5-3)7(8)9/h2H,1H3,(H,5,6)

Upstream product

• 1453-58-3 3-Methylpyrazole 
• 31230-17-8 3-methyl-5-aminopyrazole 

Downstream Products

• 400753-12-0 4-chloro-3-methyl-5-nitro-1H-pyrazole 
• 1252817-59-6 5-methyl-1-(4-methylphenyl)-3-nitro-1H-pyrazole 
• 38581-18-9 5-methyl-3-nitro-1-phenyl-1H-pyrazole 
• 1006950-51-1 2-(5-methyl-3-nitro-1H-pyrazol-1-yl)ethanol 
• 151588-03-3 1-amino-3-nitro-5-methylpyrazole 

Relevant articles and documents

INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS

The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, ring C, X1, X2, L1, R1, R2, R3, R4, R5, R6, R7, m and n are as defined herein, which are useful as MAP4K1 inhibitors, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by MAP4K1.

COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROL OF HEPATITIS C VIRAL INFECTIONS

Various tetrahydropyrazolo[1,5-a]pyrimidine compounds, compositions, methods of making, and methods for the prevention and treatment of HCV infections and associated diseases are disclosed. The invention further relates to biomarkers for identification of HCV strains which are resistant to the tetrahydropyrazolo[1,5- a]pyrimidine compounds.